News

New Directory Connecting Australia’s Medical Device Sector Launched to Drive Innovation

15 September 2020 The Medical Device Partnering Program today launches the first dedicated online Capability Directory for the medical device sector, to boost innovation and development of cutting-edge medical devices and technologies in Australia. Funded by MTPConnect, the…

Planet Innovation and Lumos Diagnostics pick up top Medical Design and Engineering Awards for rapid diagnostic development platform

15 September 2020 Planet Innovation and Lumos Diagnostics have won two awards at the 2020 Good Design Awards, including a Good Design Award Gold accolade for Lumos’s Leelu Reader. The annual Good Design Awards is Australia’s oldest and most…

Results of Cynata’s World-First Clinical Trial of iPSC-derived CYP-001 in GvHD Accepted for Publication in Nature Medicine

15 September 2020 Release date 14 September 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that a paper describing the Phase 1 clinical trial of CYP-001 in patients with graft…

Starpharma’s SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2

15 September 2020 New data generated at Scripps Research Institute in the US shows that Starpharma’s antiviral nasal spray active (SPL7013) is virucidal, inactivating more than 99.9% of SARS-CoV-2, the virus that causes COVID-19 Potent antiviral activity of…

Opening eyes to a frontier in vision restoration

15 September 2020 Release date 14 September 2020 A world-first device to restore vision to the blind is being prepared for human clinical trials in Melbourne. Additional funding can help researchers establish an implantable device manufacturing facility to…

Nucleus Network Begins Clinical Trial of COVID-19 Antibody Treatment

15 September 2020 Release date 11 September 2020 Australia’s largest Phase 1 clinical trials specialist, Nucleus Network, has this week started the first human trials of a potential COVID-19 treatment developed by Singlomics (Beijing DanXu) Biopharmaceuticals and licensed…

University accelerates the process of 3D printed nasal swabs for COVID-19 testing

15 September 2020 Release date 11 September 2020 The University of Melbourne has brought together industry partners and researchers for the development of an Australian-first; locally manufactured 3D printed nasal swab for coronavirus (COVID-19) testing. 3DMEDiTECH, a partner…

Business Survival and Adaptation Package

14 September 2020 Via Business Victoria – we will update this page as more information becomes available. About the package The Victorian Government is investing $3 billion to help businesses impacted by ongoing restrictions and prepare for COVID…

Positive results flow continues for Dimerix’s DMX-200 kidney disease therapy candidate

14 September 2020 In what has been a steadily positive research progression so far, Melbourne-based clinical-stage biopharmaceutical company Dimerix has reported a continuation of strong clinical trial results for its drug candidate DMX-200, which is aimed at a…

Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly

14 September 2020 Release date 10 September 2020 PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD) OIRD Occurred in 46% of Patients Studied Patients with Respiratory Depression Are 37%…

Gilead Sciences to Acquire Immunomedics

13 September 2020 Gilead Adds TrodelvyTM, First-in-Class Antibody-Drug Conjugate Approved to Treat Triple-Negative Breast Cancer, With Promise in Other Forms of Breast Cancer and Additional Solid Tumors Acquisition Transforms Gilead’s Portfolio with First-in-Class Commercial Product with Significant Revenue and…

Electronic Signatures and Clinical Trial Research Agreement execution in Australia

14 September 2020 Release date 12 September 2020 CT:IQ together with Medicines Australia (MA), Medical Technology Association of Australia (MTAA) and AusBiotech have released a joint position statement confirming that eSignatures can be used to execute clinical trial…

Home

News & opinion

Member Directory

Events